A solicitor who failed to spot red flags for potential fraud/money laundering while acting on two loans worth £464,000 has ...
iDenfy’s revamped AML Screening software now includes new risk categories, better PEP status labeling, and other built-in AML features Delaware, United States, October 29, 2025-- iDenfy, a global ...
TIBSOVO is a targeted therapy that works against an abnormal protein created by a mutation in the IDH1 gene. This abnormal ...
Combining proteasome inhibitors with autophagy inhibitors disrupts acute myeloid leukemia (AML) cells' proteostasis, enhancing treatment efficacy and inducing programmed cell death. The novel therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback